Overview of Libtayo, First FDA-Approved Drug for Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) When Surgery or Radiation Isn’t an Option
Libtayo (pronounced lihb-TAY-oh) falls into a category of drugs called checkpoint inhibitors, which help the immune system fight cancer. Libtayo (cemiplimab-rwlc, pronounced seh-MIP-lih-mab) is a type of drug known as…